London, United Kingdom

Shobhit Maini

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shobhit Maini: Innovator in Blockchain Technology

Introduction

Shobhit Maini is a notable inventor based in London, GB. He has made significant contributions to the field of blockchain technology, focusing on enhancing security and scalability. His innovative approach addresses critical challenges faced by conventional blockchain systems.

Latest Patents

Shobhit Maini holds a patent titled "Systems and methods for facilitating a double-layer restriction subnet architecture using subnet specific restrictions within data streamed using hierarchical subnet restrictions." This patent outlines systems and methods aimed at improving blockchain technology, particularly by providing scalable solutions to security and privacy concerns. The double-layer restriction subnet architecture he developed comprises a series of permissioned subnets, which combine the security benefits of permissioned blockchains with the scalability of subnet efficiency. He has 1 patent to his name.

Career Highlights

Shobhit Maini is currently employed at Citigroup Technology, Inc., where he applies his expertise in blockchain technology. His work focuses on developing innovative solutions that enhance the functionality and security of blockchain systems.

Collaborations

Shobhit has collaborated with notable professionals in his field, including Aharon Baruch Haber and Haiping Choo. These collaborations have further enriched his work and contributed to advancements in blockchain technology.

Conclusion

Shobhit Maini is a pioneering inventor whose work in blockchain technology is shaping the future of secure and scalable systems. His contributions are vital in addressing the evolving challenges in the digital landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…